These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 28453488)
1. Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-β Aggregation in Alzheimer's Disease. Lakey-Beitia J; González Y; Doens D; Stephens DE; Santamaría R; Murillo E; Gutiérrez M; Fernández PL; Rao KS; Larionov OV; Durant-Archibold AA J Alzheimers Dis; 2017; 60(s1):S59-S68. PubMed ID: 28453488 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors. Okuda M; Hijikuro I; Fujita Y; Teruya T; Kawakami H; Takahashi T; Sugimoto H Bioorg Med Chem Lett; 2016 Oct; 26(20):5024-5028. PubMed ID: 27624076 [TBL] [Abstract][Full Text] [Related]
3. Curcumin derivatives and Aβ-fibrillar aggregates: An interactions' study for diagnostic/therapeutic purposes in neurodegenerative diseases. Orteca G; Tavanti F; Bednarikova Z; Gazova Z; Rigillo G; Imbriano C; Basile V; Asti M; Rigamonti L; Saladini M; Ferrari E; Menziani MC Bioorg Med Chem; 2018 Aug; 26(14):4288-4300. PubMed ID: 30031653 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity. Li L; Chen M; Jiang FC Bioorg Med Chem; 2016 Apr; 24(8):1853-65. PubMed ID: 26972922 [TBL] [Abstract][Full Text] [Related]
5. Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway. Thapa A; Jett SD; Chi EY ACS Chem Neurosci; 2016 Jan; 7(1):56-68. PubMed ID: 26529184 [TBL] [Abstract][Full Text] [Related]
7. Syntheses And Evaluation Of Asymmetric Curcumin Analogues As Potential Multifunctional Agents For The Treatment Of Alzheimer's Disease. Zhai P; Xia CL; Tan JH; Li D; Ou TM; Huang SL; Gu LQ; Huang ZS Curr Alzheimer Res; 2015; 12(5):403-14. PubMed ID: 25938868 [TBL] [Abstract][Full Text] [Related]
8. Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor. Endo H; Nikaido Y; Nakadate M; Ise S; Konno H Bioorg Med Chem Lett; 2014 Dec; 24(24):5621-5626. PubMed ID: 25467149 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease. Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724 [TBL] [Abstract][Full Text] [Related]
10. Anti-arrhythmic Medication Propafenone a Potential Drug for Alzheimer's Disease Inhibiting Aggregation of Aβ: In Silico and in Vitro Studies. Ngo ST; Fang ST; Huang SH; Chou CL; Huy PD; Li MS; Chen YC J Chem Inf Model; 2016 Jul; 56(7):1344-56. PubMed ID: 27304669 [TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations. Nahar PP; Slitt AL; Seeram NP J Med Food; 2015 Jul; 18(7):786-92. PubMed ID: 25490740 [TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways. Shi X; Zheng Z; Li J; Xiao Z; Qi W; Zhang A; Wu Q; Fang Y Neurosci Lett; 2015 May; 594():105-10. PubMed ID: 25818332 [TBL] [Abstract][Full Text] [Related]
13. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8. Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836 [TBL] [Abstract][Full Text] [Related]
15. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease. Bukhari SN; Jantan I Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724 [TBL] [Abstract][Full Text] [Related]
16. The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment. Morales I; Cerda-Troncoso C; Andrade V; Maccioni RB J Alzheimers Dis; 2017; 60(2):451-460. PubMed ID: 28854504 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of curcumin analogs as β-amyloid imaging agents. Gan C; Hu J; Nan DD; Wang S; Li H Future Med Chem; 2017 Sep; 9(14):1587-1596. PubMed ID: 28841047 [TBL] [Abstract][Full Text] [Related]
18. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice. Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Hirao K; Shirai N; Sogabe T; Tooyama I Neurobiol Aging; 2015 Jan; 36(1):201-10. PubMed ID: 25179227 [TBL] [Abstract][Full Text] [Related]
19. Hybrids of oxoisoaporphine-tetrahydroisoquinoline: novel multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease. Chen Y; Su C; Wang L; Qin J; Wei S; Tang H Mol Divers; 2019 Aug; 23(3):709-722. PubMed ID: 30603938 [TBL] [Abstract][Full Text] [Related]
20. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Wang SW; Wang YJ; Su YJ; Zhou WW; Yang SG; Zhang R; Zhao M; Li YN; Zhang ZP; Zhan DW; Liu RT Neurotoxicology; 2012 Jun; 33(3):482-90. PubMed ID: 22445961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]